Global Blood Therapeutics (GBT) PT Lowered to $74 at Oppenheimer
Tweet Send to a Friend
Oppenheimer lowered its price target on Global Blood Therapeutics (NASDAQ: GBT) to $74.00 (from $79.00) while maintaining a Outperform rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
